TVM Life Science Ventures VI GmbH & Co KG Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for TVM Life Science Ventures VI GmbH & Co KG.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of TVM Life Science Ventures VI GmbH & Co KG. TVM Life Science Ventures VI GmbH & Co KG is a Director in Acer Therapeutics Inc. ($OPXA) and a Director in CONCERT PHARMACEUTICALS, INC. ($CNCE) and a 10% Owner in PROTEON THERAPEUTICS INC ($PRTO).

Address: C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 80333Germany

Companies in which TVM Life Science Ventures VI GmbH & Co KG is an Insider

Acer Therapeutics Inc.

Trading Symbol: ACER
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TVM Life Science Ventures VI GmbH & Co KG: Director
Holdings: 725,844 shares
Current Value: $740,361
Latest Transaction: Jan 12 2018
$ACER Market Capitalization: $7.21M
$ACER Previous Close: $1.02

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CONCERT PHARMACEUTICALS, INC.

Trading Symbol: CNCE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TVM Life Science Ventures VI GmbH & Co KG: Director
Holdings: 378,703 shares
Current Value: $3,389,392
Latest Transaction: Feb 20 2014
$CNCE Market Capitalization: $197.12M
$CNCE Previous Close: $8.95

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Protara Therapeutics, Inc.

Trading Symbol: TARA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of TVM Life Science Ventures VI GmbH & Co KG: 10% Owner
Holdings: 1,943,059 shares
Current Value: $3,788,965
Latest Transaction: Jun 26 2017
$TARA Market Capitalization: $31.94M
$TARA Previous Close: $1.95

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of TVM Life Science Ventures VI GmbH & Co KG

Sentiment: All, ACER, CNCE, TARA

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 12 2018OPXAAcer Therapeutics ...TVM Life Science Ventures VI G ...DirectorBuyP12.00250,0003,000,0001,422,7091.2 M to 1.4 M (+21.32 %)
Jan 12 2018OPXAAcer Therapeutics ...TVM Life Science Ventures VI G ...DirectorBuyP12.0021,271255,252248,756227.5 K to 248.8 K (+9.35 %)
Jan 12 2018OPXAAcer Therapeutics ...TVM Life Science Ventures VI G ...DirectorBuyP12.0062,062744,744725,844663.8 K to 725.8 K (+9.35 %)
Sep 27 2017OPXAAcer Therapeutics ...TVM Life Science Ventures VI G ...DirectorBuyJ0.001,172,70901,172,7090 to 1.2 M
Sep 27 2017OPXAAcer Therapeutics ...TVM Life Science Ventures VI G ...DirectorBuyJ0.00227,4850227,4850 to 227.5 K
Sep 27 2017OPXAAcer Therapeutics ...TVM Life Science Ventures VI G ...DirectorBuyJ0.00663,7820663,7820 to 663.8 K
Jun 26 2017PRTOPROTEON THERAPEUTI ...TVM Life Science Ventures VI G ...10% OwnerOption ExerciseP0.99128127500

View all TVM Life Science Ventures VI GmbH & Co KG insider transactions.